272 related articles for article (PubMed ID: 22715379)
1. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
[TBL] [Abstract][Full Text] [Related]
2. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.
Chiodi V; Ferrante A; Ferraro L; Potenza RL; Armida M; Beggiato S; Pèzzola A; Bader M; Fuxe K; Popoli P; Domenici MR
J Neurochem; 2016 Mar; 136(5):907-17. PubMed ID: 26526685
[TBL] [Abstract][Full Text] [Related]
3. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P
J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum.
Orrú M; Quiroz C; Guitart X; Ferré S
Neuropharmacology; 2011; 61(5-6):967-74. PubMed ID: 21752341
[TBL] [Abstract][Full Text] [Related]
5. Cocaine-induced changes of synaptic transmission in the striatum are modulated by adenosine A2A receptors and involve the tyrosine phosphatase STEP.
Chiodi V; Mallozzi C; Ferrante A; Chen JF; Lombroso PJ; Di Stasi AM; Popoli P; Domenici MR
Neuropsychopharmacology; 2014 Feb; 39(3):569-78. PubMed ID: 23989619
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.
Peterson JD; Goldberg JA; Surmeier DJ
Neurobiol Dis; 2012 Jan; 45(1):409-16. PubMed ID: 21964253
[TBL] [Abstract][Full Text] [Related]
7. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
[TBL] [Abstract][Full Text] [Related]
8. Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors.
Rossi S; De Chiara V; Musella A; Mataluni G; Sacchetti L; Siracusano A; Bernardi G; Usiello A; Centonze D
Mol Nutr Food Res; 2010 Apr; 54(4):525-31. PubMed ID: 20087854
[TBL] [Abstract][Full Text] [Related]
9. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.
Pardo M; López-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
Behav Brain Res; 2013 Jun; 247():217-26. PubMed ID: 23557694
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.
Garção P; Szabó EC; Wopereis S; Castro AA; Tomé ÂR; Prediger RD; Cunha RA; Agostinho P; Köfalvi A
Br J Pharmacol; 2013 Aug; 169(7):1600-11. PubMed ID: 23638679
[TBL] [Abstract][Full Text] [Related]
11. Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
Justinová Z; Ferré S; Redhi GH; Mascia P; Stroik J; Quarta D; Yasar S; Müller CE; Franco R; Goldberg SR
Addict Biol; 2011 Jul; 16(3):405-15. PubMed ID: 21054689
[TBL] [Abstract][Full Text] [Related]
12. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
[TBL] [Abstract][Full Text] [Related]
13. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors.
Centonze D; Picconi B; Baunez C; Borrelli E; Pisani A; Bernardi G; Calabresi P
Neuropsychopharmacology; 2002 Feb; 26(2):164-75. PubMed ID: 11790512
[TBL] [Abstract][Full Text] [Related]
14. Effects of cocaine self-administration and extinction on D2 -like and A2A receptor recognition and D2 -like/Gi protein coupling in rat striatum.
Frankowska M; Marcellino D; Adamczyk P; Filip M; Fuxe K
Addict Biol; 2013 May; 18(3):455-66. PubMed ID: 22500978
[TBL] [Abstract][Full Text] [Related]
15. Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.
Orrú M; Zanoveli JM; Quiroz C; Nguyen HP; Guitart X; Ferré S
Exp Neurol; 2011 Nov; 232(1):76-80. PubMed ID: 21867705
[TBL] [Abstract][Full Text] [Related]
16. The activity of the Striatal-enriched protein tyrosine phosphatase in neuronal cells is modulated by adenosine A
Mallozzi C; Pepponi R; Visentin S; Chiodi V; Lombroso PJ; Bader M; Popoli P; Domenici MR
J Neurochem; 2020 Feb; 152(3):284-298. PubMed ID: 31520531
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.
Ferre S; Ciruela F; Borycz J; Solinas M; Quarta D; Antoniou K; Quiroz C; Justinova Z; Lluis C; Franco R; Goldberg SR
Front Biosci; 2008 Jan; 13():2391-9. PubMed ID: 17981720
[TBL] [Abstract][Full Text] [Related]
18. Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain.
Kubrusly RC; Bhide PG
Neuropharmacology; 2010 Feb; 58(2):436-43. PubMed ID: 19765599
[TBL] [Abstract][Full Text] [Related]
19. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Gołembiowska K; Wardas J; Noworyta-Sokołowska K; Kamińska K; Górska A
Neurotox Res; 2013 Jul; 24(1):29-40. PubMed ID: 23296550
[TBL] [Abstract][Full Text] [Related]
20. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Ward RP; Dorsa DM
Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
